Tsunefusa Hayashida

发表

Successful efavirenz dose reduction in HIV type 1-infected individuals with cytochrome P450 2B6 *6 and *26.

S. Matsushita, S. Oka, T. Koike, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Conserved temperature-dependent expression of RNA-binding proteins in cyanobacteria with different temperature optima.

M. Ohmori, S. Ehira, N. Sato, 2003, FEMS microbiology letters.

Colonic cytomegalovirus detection by mucosal PCR and antiviral therapy in ulcerative colitis

S. Oka, J. Akiyama, N. Uemura, 2017, PloS one.

Single nucleotide polymorphisms in ABCC2 associate with tenofovir-induced kidney tubular dysfunction in Japanese patients with HIV-1 infection: a pharmacogenetic study.

S. Oka, K. Higasa, H. Gatanaga, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Drug Transporter Genetic Variants Are Not Associated with TDF-Related Renal Dysfunction in Patients with HIV-1 Infection: A Pharmacogenetic Study

S. Oka, Noriko Tanaka, H. Gatanaga, 2015, PloS one.

High plasma concentrations of dolutegravir in patients with ABCG2 genetic variants

S. Oka, H. Gatanaga, Tsunefusa Hayashida, 2017, Pharmacogenetics and genomics.

Trends in early and late diagnosis of HIV-1 infections in Tokyoites from 2002 to 2010.

S. Oka, H. Gatanaga, Y. Kikuchi, 2012, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Low Raltegravir Concentration in Cerebrospinal Fluid in Patients With ABCG2 Genetic Variants

S. Oka, H. Gatanaga, Tsunefusa Hayashida, 2014, Journal of acquired immune deficiency syndromes.

Prophylactic effect of antiretroviral therapy on hepatitis B virus infection.

S. Oka, H. Gatanaga, J. Tanuma, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efavirenz-induced neurological symptoms in rare homozygote CYP2B6 *2/*2 (C64T)

T. Hattori, K. Teruya, Tsunefusa Hayashida, 2007, International journal of STD & AIDS.

Successful treatment by doravirine with cobicistat-boosted darunavir for end-stage renal failure under chronic haemodialysis.

Koji Watanabe, A. Hirano, J. Masuda, 2021, The Journal of antimicrobial chemotherapy.

Effects of low HIV type 1 load and antiretroviral treatment on IgG-capture BED-enzyme immunoassay.

S. Oka, H. Gatanaga, J. Tanuma, 2008, AIDS research and human retroviruses.

Combination of V106I and V179D Polymorphic Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confers Resistance to Efavirenz and Nevirapine but Not Etravirine

S. Oka, Hironori Sato, H. Ode, 2010, Antimicrobial Agents and Chemotherapy.

Potential for immune-driven viral polymorphisms to compromise antiretroviral-based preexposure prophylaxis for prevention of HIV-1 infection

M. Carrington, M. John, S. Mallal, 2017, AIDS.

Naturally selected rilpivirine-resistant HIV-1 variants by host cellular immunity.

W. Sugiura, S. Oka, H. Ode, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Identification of a current hot spot of HIV type 1 transmission in Mongolia by molecular epidemiological analysis.

S. Oka, H. Gatanaga, Tsunefusa Hayashida, 2011, AIDS research and human retroviruses.

PCR detection of human herpesviruses in colonic mucosa of individuals with inflammatory bowel disease: Comparison with individuals with immunocompetency and HIV infection

S. Oka, J. Akiyama, N. Uemura, 2017, PloS one.

Emergence of CXCR4-tropic HIV-1 variants followed by rapid disease progression in hemophiliac slow progressors

S. Oka, H. Gatanaga, Y. Kikuchi, 2017, PloS one.

Full-Genome Analysis of Hepatitis C Virus in Japanese and Non-Japanese Patients Coinfected With HIV-1 in Tokyo

S. Oka, M. Sugiyama, M. Mizokami, 2019, Journal of acquired immune deficiency syndromes.

Full‐genome analysis of hepatitis C virus in HIV‐coinfected hemophiliac Japanese patients

S. Oka, M. Sugiyama, M. Mizokami, 2020, Hepatology research : the official journal of the Japan Society of Hepatology.

Rilpivirine resistance mutation E138K in HIV-1 reverse transcriptase predisposed by prevalent polymorphic mutations.

W. Sugiura, S. Oka, H. Ode, 2016, The Journal of antimicrobial chemotherapy.

Impact of human leukocyte antigen-B*51-restricted cytotoxic T-lymphocyte pressure on mutation patterns of nonnucleoside reverse transcriptase inhibitor resistance

S. Oka, Hironori Sato, H. Ode, 2010, AIDS.

Validation of mailed via postal service dried blood spot cards on commercially available HIV testing systems.

S. Oka, H. Gatanaga, Tsunefusa Hayashida, 2021, Global health & medicine.

Neutralization activity of IgG antibody in COVID‑19‑convalescent plasma against SARS-CoV-2 variants

S. Oka, Y. Takamatsu, S. Kutsuna, 2023, Scientific Reports.

Arginine insertion and loss of N-linked glycosylation site in HIV-1 envelope V3 region confer CXCR4-tropism

S. Oka, Hironori Sato, H. Ode, 2013, Scientific Reports.

Trends in transmitted drug-resistant HIV-1 and demographic characteristics of newly diagnosed patients: nationwide surveillance from 2003 to 2008 in Japan.

W. Sugiura, S. Oka, T. Koike, 2010, Antiviral research.

Allele and Genotype Frequencies of Cytochrome P450 2B6 Gene in a Mongolian Population

S. Oka, H. Gatanaga, Tsunefusa Hayashida, 2009, Drug Metabolism and Disposition.

Brief Report: High Peak Level of Plasma Raltegravir Concentration in Patients With ABCB1 and ABCG2 Genetic Variants

S. Oka, H. Gatanaga, Tsunefusa Hayashida, 2016, Journal of acquired immune deficiency syndromes.

The second molecular epidemiological study of HIV infection in Mongolia between 2010 and 2016

S. Oka, Tsunefusa Hayashida, K. Tsuchiya, 2017, PloS one.

Association of demographics, HCV co‐infection, HIV‐1 subtypes and genetic clustering with late HIV diagnosis: a retrospective analysis from the Japanese Drug Resistance HIV‐1 Surveillance Network

S. Matsushita, M. Koga, T. Matano, 2023, Journal of the International AIDS Society.